Navigation Links
BN ProSpec System

ProductsBN ProSpec System
Company Dade Behring, Inc.
Item BN ProSpec System
Features 
  • Antigen excess security through optimized reaction conditions and pre-reaction protocols
  • Broad continouosly extended assay menu
  • Calibration of various assays in parallel using multi-analyte standards
  • Excellent assay precision and recovery of controls
  • Flexible combination of various types of sample tubes on any one segment
  • Full barcode identification of samples, controls, standards and reagents
  • Fully automated sample processing including customized re-measurements
  • More than 60 assay protocols allow determinations in serum, plasma, urine and CSF
  • Patient-oriented sample processing
  • Refrigerated on-board storage of controls and reagents
  • Description The BN ProSpec, the system of choice for customers performing routine and specialty Plasma Protein assays in medium throughput laboratories in more than 50 countries worldwide has achieved a new milestone. Dade Behring is pleased to announce the placement of the 1000th BN ProSpec system.

    The customer centered development process of the BN ProSpec; system contributed significantly to such wide acceptance and has been recently recognized with the achievement of the 2003 International Project Management Award (IPMA). This process allows our customers to be involved in the development of system features.
    Info Dade Behring, Inc.Call Dade Behring, Inc. to buy products (US and Canada only; other locations use number below) USACanada1-866-262-8155

    Customer Service: 1-847-267-5300
    Web site: http://www.dadebehring.com

    Related medicine products :

    1. ProSpecT Shiga Toxin E. coli (STEC) Microplate Assay
    2. Silicone Oil Cannula System - 20 Gauge
    3. Silicone Oil Cannula System - 19 Gauge
    4. SuperVu Galilean System
    5. KOWA nonmyd 7 / VK-2 Digital Imaging System
    6. KOWA nonmyd a-D / VK-2 Digital Imaging System
    7. Refraction System RT-2100
    8. Odyssey Phacoemulsification System
    9. SIStem Phacoemulsification System
    10. Precisionist Phacoemulsification System
    11. Photon Laser Phacoemulsification System
    ...AREDS formula is the one and only vitamin and mine...nstitute's age-related eye study (AREDS) 10-year t...cal Age-Related Eye Disease Study (AREDS) by the N...Institutes of Health) showed that a unique vitamin...
    Ocuvite® Eye Vitamins and Mineral Supplement
    ...aps, the patented next-generation dietary suppleme...systemically address the root inflammatory cause a... peer-reviewed literature that these specific nutr...ther affected parts of the body, such as mucous me...
    ...the industry-leading portal to QC information, pro... way to access their quality control data and othe...b enables Bio-Rad customers to access on-demand (I...s, as well as convenient online data entry and man...
    Medicine Products:
    (Date:11/7/2009)...d for Life Action endorses a key vote today on the...Dahlkemper-Lipinski-Smith Amendment, an Amendment ...on in health care reform. ,, Americans United for ...t said, "Americans United for Life Action strongly...mper-Lipinski-Smith Amendment to prohibit abortion...
    (Date:11/7/2009)...uth will rebel, expert says , , SATURDAY, ...o behave badly if their parents expect them to, a ...hey are simply being realistic might actually cont...hanan, a psychology professor at Wake Forest Unive...sity news release. "Negative expectations on the p...
    (Date:11/7/2009)...-25th marked the 12th annual tournament bringing t...e against pediatric cancer. Stephen Updegraff, MD...r many years. , St. Peter...d of October 23-25 marked the 12th annual tournam...ting the battle against pediatric cancer– To...
    (Date:11/7/2009)...quo;sweatox’ or ‘Boytox’, the ne...i-ageing jab ‘Breastox’ – or bre...colletage, can reduce the appearance of wrinkles a...sts, leaving smoother, younger-looking skin. , ...Transform, the UK’s largest group of cosmet...
    (Date:11/6/2009)...ER, Nov. 6 /PRNewswire-FirstCall/ - Cardiome Pharm...d that it will report financial results for the th...g of Monday, November 9, 2009. Cardiome will hold ...n (6:00am Pacific) on that day to discuss the resu... 416-695-7806 or 888-789-9572 and reference confer...
    Breaking Medicine News(10 mins):Health News:Americans United for Life Action Endorses a Vote for the Stupak-Ellsworth-Pitts-Kaptur-Dahlkemper-Lipinski-Smith Amendment and Sends Score Letter to House Members 2Health News:Bad-Behaving Teens May Be Living Up to Expectations 2Health News:Updegraff Vision Proudly Supports The Pediatric Cancer Foundation 2Health News:Updegraff Vision Proudly Supports The Pediatric Cancer Foundation 3Health News:UK Boobs Get a Boost with 'Breastox' 2Health News:Cardiome to Release Third Quarter Results 2Health News:Cardiome to Release Third Quarter Results 3
    ...A new study has found that single tablets containi...olling increasing blood pressure in people with e...al study named ACCOMPLISH (Avoiding Cardiovascular...niversity of Michigan Medical School. As p...
    ...Stanford University School of Medicine researchers...of the body's immune system known as troublemaker...ficial for metabolism. The new finding is ...eputation for being the bad guys. We have found th...
    ...The lives of laborers begin from mines and end wit...desh. Forced to work in illegal stone quarries b...o silica dust puts the laborers at high risk of ge...villages of Madhya Pradesh's Morena district. ...
    ...A new study has found that apart from using mobile...f passengers in a vehicle could increase the risk...itute for International Health, was intended to de...und that passengers also contribute to road accide...
    ...Addressing the concerns of developing countries li...World Health Organization (WHO), has promised eff...istribution of pandemic influenza vaccines at affo... A resolution on those lines is being adopted by t...
    ...One almost freezes in horror watching the ghastly ...ocks, on the ground then, covering her head as sto...shed with a concrete block, blood oozes from her h...ad, 17, was to love a boy from another religion. S...
    Other Medicine News:Health News:Single-tablet With Two Drugs may Help Control High BP Better 2Health News:Macrophages may Help Prevent Obesity 2Health News:Miners in Madhya Pradesh at High Risk of Developing TB 2Health News:Not Only Mobile Phones, Even Passengers can Increase the Risk of Road Accidents 2Health News:WHO Announces Deal on Sharing Bird Flu Virus 2Health News:Women in Iraq More Unsafe Than Ever 2
    (Date:11/6/2009)... -- Philips Respironics applauds the efforts of th... to raise awareness about an important public heal... release of the first-ever government study to mon...s a milestone in quantifying the size and scope of...stry leader and sleep therapy manufacturer, Philip...
    (Date:11/6/2009).../ -- Cyberonics, Inc. (Nasdaq: CYBX ) today annou...s for the second quarter ended October 23, 2009 of...y, November 18, 2009 at 5:00 PM EST. The company ...sults on Thursday, November 19, 2009 at 9:00 AM ES... Conference Call Instructions ,, To listen to...
    (Date:11/6/2009)... , - Trial Will Compare NXL103 With Leadi...-Resistant Staphylococcus Aureus (MRSA) Infections...ompany focused on the discovery and,development of...icant global,problem of microbial resistance, anno...ial NXL103 (flopristin/linopristin), has started a...
    Breaking Medicine Technology:Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 Second Quarter Financial Results 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Angiotechs Licensee Cook Medical Announces CE Mark Approval and European Launch of the Zilver 28R 29 PTX 28R 29 Stent 13489 1Angiotechs Licensee Cook Medical Announces CE Mark Approval and European Launch of the Zilver 28R 29 PTX 28R 29 Stent 13489 2Angiotechs Licensee Cook Medical Announces CE Mark Approval and European Launch of the Zilver 28R 29 PTX 28R 29 Stent 13489 3Angiotechs Licensee Cook Medical Announces CE Mark Approval and European Launch of the Zilver 28R 29 PTX 28R 29 Stent 13489 4Angiotechs Licensee Cook Medical Announces CE Mark Approval and European Launch of the Zilver 28R 29 PTX 28R 29 Stent 13489 5Angiotechs Licensee Cook Medical Announces CE Mark Approval and European Launch of the Zilver 28R 29 PTX 28R 29 Stent 13489 6Angiotechs Licensee Cook Medical Announces CE Mark Approval and European Launch of the Zilver 28R 29 PTX 28R 29 Stent 13489 7Angiotechs Licensee Cook Medical Announces CE Mark Approval and European Launch of the Zilver 28R 29 PTX 28R 29 Stent 13489 8DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 1DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 2DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 3DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 4DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 5DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 6DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 7DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 8DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 9DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 10DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 11DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 12DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 13Rockport Healthcare Group Continues to Grow Coverage Area With New Work Comp Network Certification in Georgia 54149 1Rockport Healthcare Group Continues to Grow Coverage Area With New Work Comp Network Certification in Georgia 54149 2